Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease

Anna Alisi, Valerio Nobili, Sara Ceccarelli, Nadia Panera, Cristiano De Stefanis, Rita De Vito, Roberta Vitali, Giorgio Bedogni, Clara Balsano, Salvatore Cucchiara, Laura Stronati

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Non-alcoholic fatty liver disease (NAFLD) affects 3-12% of the general pediatric population. HMGB1 protein is presently considered a potent inflammatory mediator in several liver diseases, even if its role in NAFLD is still unknown in clinical studies. Here we investigated the relationships between circulating HMGB1, TGF-β and MCP-1 and liver damage in pediatric NAFLD. HMGB1, TGF-β and MCP-1 plasma levels were measured in 110 obese children with biopsy-proven NAFLD and 40 age-matched obese controls. HMGB1, TGF-β and MCP-1, ALT, AST and cholesterol plasma levels were significantly higher in NAFLD than in control children. A significant association between increased levels of HMGB1, TGF-β and MCP-1 and high degrees of fibrosis was found. In this study, we showed for the first time that circulating levels of HMGB1 were raised in children with NAFLD and strongly correlated with fibrosis and systemic inflammation.

Original languageEnglish
Pages (from-to)763-771
Number of pages9
JournalExpert Review of Molecular Diagnostics
Volume14
Issue number6
DOIs
Publication statusPublished - 2014

Fingerprint

HMGB1 Protein
Fibrosis
Pediatrics
Non-alcoholic Fatty Liver Disease
Liver Diseases
Cholesterol
Inflammation
Biopsy
Liver
Population

Keywords

  • High mobility group box 1
  • Liver fibrosis
  • Monocyte chemoattractant protein-1
  • Non-alcoholic fatty liver disease
  • TGF β

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease. / Alisi, Anna; Nobili, Valerio; Ceccarelli, Sara; Panera, Nadia; De Stefanis, Cristiano; De Vito, Rita; Vitali, Roberta; Bedogni, Giorgio; Balsano, Clara; Cucchiara, Salvatore; Stronati, Laura.

In: Expert Review of Molecular Diagnostics, Vol. 14, No. 6, 2014, p. 763-771.

Research output: Contribution to journalArticle

Alisi, Anna ; Nobili, Valerio ; Ceccarelli, Sara ; Panera, Nadia ; De Stefanis, Cristiano ; De Vito, Rita ; Vitali, Roberta ; Bedogni, Giorgio ; Balsano, Clara ; Cucchiara, Salvatore ; Stronati, Laura. / Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease. In: Expert Review of Molecular Diagnostics. 2014 ; Vol. 14, No. 6. pp. 763-771.
@article{192ad633f4774b97aaf8c320fc90c1fe,
title = "Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease",
abstract = "Non-alcoholic fatty liver disease (NAFLD) affects 3-12{\%} of the general pediatric population. HMGB1 protein is presently considered a potent inflammatory mediator in several liver diseases, even if its role in NAFLD is still unknown in clinical studies. Here we investigated the relationships between circulating HMGB1, TGF-β and MCP-1 and liver damage in pediatric NAFLD. HMGB1, TGF-β and MCP-1 plasma levels were measured in 110 obese children with biopsy-proven NAFLD and 40 age-matched obese controls. HMGB1, TGF-β and MCP-1, ALT, AST and cholesterol plasma levels were significantly higher in NAFLD than in control children. A significant association between increased levels of HMGB1, TGF-β and MCP-1 and high degrees of fibrosis was found. In this study, we showed for the first time that circulating levels of HMGB1 were raised in children with NAFLD and strongly correlated with fibrosis and systemic inflammation.",
keywords = "High mobility group box 1, Liver fibrosis, Monocyte chemoattractant protein-1, Non-alcoholic fatty liver disease, TGF β",
author = "Anna Alisi and Valerio Nobili and Sara Ceccarelli and Nadia Panera and {De Stefanis}, Cristiano and {De Vito}, Rita and Roberta Vitali and Giorgio Bedogni and Clara Balsano and Salvatore Cucchiara and Laura Stronati",
year = "2014",
doi = "10.1586/14737159.2014.928205",
language = "English",
volume = "14",
pages = "763--771",
journal = "Expert Review of Molecular Diagnostics",
issn = "1473-7159",
publisher = "Expert Reviews Ltd.",
number = "6",

}

TY - JOUR

T1 - Plasma high mobility group box 1 protein reflects fibrosis in pediatric nonalcoholic fatty liver disease

AU - Alisi, Anna

AU - Nobili, Valerio

AU - Ceccarelli, Sara

AU - Panera, Nadia

AU - De Stefanis, Cristiano

AU - De Vito, Rita

AU - Vitali, Roberta

AU - Bedogni, Giorgio

AU - Balsano, Clara

AU - Cucchiara, Salvatore

AU - Stronati, Laura

PY - 2014

Y1 - 2014

N2 - Non-alcoholic fatty liver disease (NAFLD) affects 3-12% of the general pediatric population. HMGB1 protein is presently considered a potent inflammatory mediator in several liver diseases, even if its role in NAFLD is still unknown in clinical studies. Here we investigated the relationships between circulating HMGB1, TGF-β and MCP-1 and liver damage in pediatric NAFLD. HMGB1, TGF-β and MCP-1 plasma levels were measured in 110 obese children with biopsy-proven NAFLD and 40 age-matched obese controls. HMGB1, TGF-β and MCP-1, ALT, AST and cholesterol plasma levels were significantly higher in NAFLD than in control children. A significant association between increased levels of HMGB1, TGF-β and MCP-1 and high degrees of fibrosis was found. In this study, we showed for the first time that circulating levels of HMGB1 were raised in children with NAFLD and strongly correlated with fibrosis and systemic inflammation.

AB - Non-alcoholic fatty liver disease (NAFLD) affects 3-12% of the general pediatric population. HMGB1 protein is presently considered a potent inflammatory mediator in several liver diseases, even if its role in NAFLD is still unknown in clinical studies. Here we investigated the relationships between circulating HMGB1, TGF-β and MCP-1 and liver damage in pediatric NAFLD. HMGB1, TGF-β and MCP-1 plasma levels were measured in 110 obese children with biopsy-proven NAFLD and 40 age-matched obese controls. HMGB1, TGF-β and MCP-1, ALT, AST and cholesterol plasma levels were significantly higher in NAFLD than in control children. A significant association between increased levels of HMGB1, TGF-β and MCP-1 and high degrees of fibrosis was found. In this study, we showed for the first time that circulating levels of HMGB1 were raised in children with NAFLD and strongly correlated with fibrosis and systemic inflammation.

KW - High mobility group box 1

KW - Liver fibrosis

KW - Monocyte chemoattractant protein-1

KW - Non-alcoholic fatty liver disease

KW - TGF β

UR - http://www.scopus.com/inward/record.url?scp=84903216539&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903216539&partnerID=8YFLogxK

U2 - 10.1586/14737159.2014.928205

DO - 10.1586/14737159.2014.928205

M3 - Article

C2 - 24927058

AN - SCOPUS:84903216539

VL - 14

SP - 763

EP - 771

JO - Expert Review of Molecular Diagnostics

JF - Expert Review of Molecular Diagnostics

SN - 1473-7159

IS - 6

ER -